AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 16th, 2007 • Depomed Inc • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) to Stock Purchase Agreement is made as of February 8, 2007 by and between Biovail Laboratories International SRL, an International Society with Restricted Liability under the laws of Barbados (“Purchaser”), and Depomed, Inc., a California corporation (the “Company”).
DEPOMED, INC. NONSTATUTORY STOCK OPTION AGREEMENTNonstatutory Stock Option Agreement • March 16th, 2007 • Depomed Inc • Pharmaceutical preparations • California
THIS NONSTATUTORY STOCK OPTION AGREEMENT (the “Agreement”) is made and entered into as of the date set forth in Item B above (the “Grant Date”) between DepoMed, Inc., a California corporation (the “Company”), and the person named in Item A above (“Optionee”).
MOVA Pharmaceutical Corporation and Depomed, Inc. COMMERCIAL MANUFACTURING AGREEMENTAgreement • March 16th, 2007 • Depomed Inc • Pharmaceutical preparations • Puerto Rico
THIS AGREEMENT is executed as of this 19th day of December, 2006 and effective as of June 1, 2006 (the “Effective Date”), by and between MOVA Pharmaceutical Corporation (“MOVA”), a corporation organized under the laws of the Commonwealth of Puerto Rico, having its principal place of business at Villa Blanca Industrial Park, State Road No. 1, Km. 34.5,Caguas, Puerto Rico, and Depomed, Inc. (“DEPOMED”), a corporation organized under the laws of the State of California, having its principal place of business at 1360 O’Brien Drive, Menlo Park, California 94025. MOVA and DEPOMED each shall sometimes be referred to herein sometimes as a “Party” and collectively as the “Parties.”
DEPOMED, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • March 16th, 2007 • Depomed Inc • Pharmaceutical preparations • California
THIS INCENTIVE STOCK OPTION AGREEMENT (the “Agreement”) is made and entered into as of the date set forth in Item B above (the “Grant Date”) between Depomed, Inc., a California (the “Company”), and the person named in Item A above (“Optionee”).
SUBLICENSE AGREEMENTSublicense Agreement • March 16th, 2007 • Depomed Inc • Pharmaceutical preparations • California
This Sublicense Agreement (this “Agreement”) is made as of October 13, 2006 (the “Effective Date”) by and between PharmaNova Inc. a Delaware corporation with its principal place of business located at 50 Lucius Gordon Drive, Ste 206, West Henrietta, NY 14586 (“Licensor”), and Depomed, Inc., a California corporation with its principal place of business located at 1360 O’Brien Drive, Menlo Park, CA 94025 (“Licensee”) (each, a “Party” and collectively, the “Parties”).
